Use of mesenchymal stem cells in the combination therapy of ulcerative colitis

by O V Knyazev, A I Parfenov, A G Konoplyannikov, O N Boldyreva
Published 2016-02-01

Value of adhesion molecules for evaluating the efficiency of therapy for ulcerative colitis and Crohn's disease

by A I Parfenov, O N Boldyreva, I N Ruchkina, O V Kniazev, V É Sagynbaeva, P L Shcherbakov, S G Khomeriki, L B Lazebnik, A G Konopliannikov
Published 2014-02-01

Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy

by O V Knyazev, A V Kagramanova, N A Fadeeva, A A Lishchinskaya, O N Boldyreva, K K Noskova, R B Gudkova, A G Konoplyannikov, A I Parfenov
Published 2018-02-01

Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: Results of a 5-year follow-up

by O V Kniazev, A I Parfenov, A G Konopliannikov, I N Ruchkina, A A Churikova, S V Bykova, E A Albulova, O N Boldyreva, N A Fadeeva, A A Lishchinskaia
Published 2015-02-01

Efficacy of adalimumab for Crohn’s disease in real clinical practice

by O V Knyazev, A V Kagramanova, I N Ruchkina, N A Fadeeva, A A Lishchinskaya, O N Boldyreva, E Yu Zhulina, P L Shcherbakov, N V Orlova, M V Kirova, A I Parfenov
Published 2017-02-01